The short version of IRAP fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-12. Anything still debated is marked as such rather than presented as settled.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
transcription unit The segment of DNA between the initiation site and the termination site of transcription, containing the coding sequences for one or more genes. All genes within a transcription unit are transcribed together into a single transcript during a single transcription event; the resulting polycistronic RNA may subsequently be cleaved into separate RNAs, or may be translated as a unit and then cleaved into separate polypeptides.
He defeated Čilić in his first match, but lost his final two matches and did not advance out of his round robin group. Zverev finished the year ranked No. 4, peaking at No. 3 right before the ATP Finals, and accumulated five ATP titles from just six finals.
With the destruction of the Zaporizhian Sich, a number of Ukrainian-speaking Eastern Orthodox Zaporozhian Cossacks fled to the territory under the control of the Ottoman Empire. Together with Cossacks of Greater Russian origin, as well as the vast majority of Old Believers and other people from "Greater Russia" (Muscovy), they settled in the area of the Danube river, and founded a new Sich. Many Ukrainian peasants and adventurers later joined the Danubian Sich. While Ukrainian folklore remembers the Danubian Sich, other new siches of Loyal Zaporozhians on the Bug and Dniester rivers did not achieve such fame. Other Cossacks settled on the Tisa river in the Austrian Empire, also forming a new Sich. During the Cossack sojourn under Turkish rule, a new host was founded that numbered around 12,000 people by the end of 1778. Cossack settlement on the Russian border was approved by the Ottoman Empire after the Cossacks officially vowed to serve the sultan. Yet internal conflict, and the political maneuvering of the Russian Empire led to splits among the Cossacks. Some of the runaway Cossacks returned to Russia, where the Russian army used them to form new military bodies that also incorporated Greeks, Albanians and Crimean Tatars. After the Russo-Turkish war of 1787–1792, most of these Cossacks were absorbed into the Black Sea Cossack Host together with Loyal Zaporozhians. Most of the remaining Cossacks who had stayed in the Danube Delta returned to Russia in 1828. They settled in the area north of the Azov Sea, becoming known as the Azov Cossacks.
== External links == MedlinePlus Encyclopedia: Gamma-glutamyl transpeptidase (GGT) blood test gamma-Glutamyltransferase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) GGT - Lab Tests Online Overview of all the structural information available in the PDB for UniProt: P19440 (Gamma-glutamyltransferase 1) at the PDBe-KB.
Bottles are commonly used for liquid pharmaceuticals as well as formed tablets and capsules. Glass is most common for liquids because it is inert and has excellent barrier properties. Various types of plastic bottles are used both by drug producers as well as by pharmacists in a pharmacy. Prescription bottles have been around since the 19th century. Throughout the 19th and 20th centuries, prescription medication bottles were called medicinal bottles. There are many styles and shapes of prescription bottles. Bottles would often include cotton to cushion powdery, breakable pills. In modern times, pills are coated, and thus the inclusion of a cotton ball is no longer necessary. The U.S. National Institute of Health recommends consumers remove any cotton balls from opened pill bottles, as cotton balls may attract moisture into the bottle. Prescription bottles come in several different colors, the most common of which being orange or light brown due to its ability to prevent ultraviolet light from degrading the potentially photosensitive contents through photochemical reactions, while still letting enough visible light through for the contents to be easily visible. Other common colors include: Clear (for compounds that don't degrade in light), blue, dark brown, green, and various opaque hues.
Sources: en.wikipedia.org
Ion milling is a specialized physical etching technique that is a crucial step in the preparation of material analysis techniques. After a specimen goes through ion milling, the surface becomes much smoother and more defined, which allows scientists to study the material much easier. The ion mill generates high-energy particles to remove material off the surface of a specimen, similar to how sand and dust particles wear away at rocks in a canyon to create a smooth surface. Relative to other techniques, ion milling creates much less surface damage, which makes it perfect for surface-sensitive analytical techniques. This article discusses the principle, equipment, applications, and significance of ion milling.
== Side effects == The side effects of nicergoline are usually limited to nausea, hot flushes, mild gastric upset, hypotension and dizziness. At high drug dosages, bradycardia, increased appetite, agitation, diarrhea and perspiration were reported. Most of the available literature suggests that the side effects of nicergoline are mild and transient.
The Global Carbon Budget 2021 concludes that fossil CO2 emissions rebounded by around +4.8% relative to 2020 emissions – returning to 2019 levels, identifies three major issues for improving reliable accuracy of monitoring, shows that China and India surpassed 2019 levels (by 5.7% and 3.2%) while the EU and the US stayed beneath 2019 levels (by 5.3% and 4.5%), quantifies various changes and trends, for the first time provides models' estimates that are linked to the official country GHG inventories reporting, and shows that the remaining carbon budget at 1. Jan 2022 for a 50% likelihood to limit global warming to 1.5 °C is 120 GtC (420 GtCO2) – or 11 years of 2021 emissions levels. Scientists propose and preliminarily evaluate a likely transgressed planetary boundary for green water in the water cycle, measured by root-zone soil moisture deviation from Holocene variability. A study published one day earlier integrates "green water" along with "blue water" into an index to measure and project water scarcity in agriculture for climate change scenarios. 27 April A lineage of H3N8 bird flu is found to infect humans for the first time, with a case reported in the Henan province of China. Months earlier, H5 strain bird flu viruses (HPAIv) have been detected in Canada and the US. A study extends global assessments of shares of species threatened by extinction with reptiles, which often play functional roles in their respective ecosystems, indicating at least 21% are threatened by extinction.
Thin-layer chromatography (TLC) is a chromatography technique that separates components in non-volatile mixtures. It is performed on a TLC plate made up of a non-reactive solid coated with a thin layer of adsorbent material. This is called the stationary phase. The sample is deposited on the plate, which is eluted with a solvent or solvent mixture known as the mobile phase (or eluent). This solvent then moves up the plate via capillary action. As with all chromatography, some compounds are more attracted to the mobile phase, while others are more attracted to the stationary phase. Therefore, different compounds move up the TLC plate at different speeds and become separated. To visualize colourless compounds, the plate is viewed under UV light or is stained. Testing different stationary and mobile phases is often necessary to obtain well-defined and separated spots. TLC is quick, simple, and gives high sensitivity for a relatively low cost. It can monitor reaction progress, identify compounds in a mixture, determine purity, or purify small amounts of compound.
Sources: en.wikipedia.org
==== Shotgun sequencing ==== High throughput shotgun sequencing using tools such as Solexa or Illumina yields approximately 5 million sequence tags per sample of maternal serum. Aneuploid pregnancies such as trisomy were identified when testing at the fourteenth week of gestation. Fetal whole of genome mapping by parental haplotype analysis was completed using sequencing of cffDNA from maternal serum. Pregnant females were studied using a 2-plex massively parallel maternal plasma DNA sequencing and trisomy was diagnosed with z-score greater than 3. The sequencing gave sensitivity of 100 percent, specificity of 97.9 percent, a positive predictive value of 96.6 percent and a negative predictive value of 100 percent.
Ketazolam (marketed under the brand names Anseren, Ansieten, Ansietil, Marcen, Sedatival, Sedotime, Solatran and Unakalm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
1 June – Roy Taylor, singer and bass player. 3 June – Conor O'Brien, 18th Baron Inchiquin, 79, peer. Born in England. 6 June – Teddy McCarthy, 57, hurler and Gaelic footballer (Sarsfields, Glanmire, Cork senior teams, Munster). 8 June – Paul Coghlan, 79, politician, Senator (1997–2020). 11 June – Michael A. Noonan, 82, television writer. 13 June – Christy Dignam, 63, singer (Aslan). 19 June – Jim McCourt, 79, boxer, Olympic bronze medallist (1964). Born in Northern Ireland. 21 June – Ronnie Nolan, 89, footballer (Shamrock Rovers, Bohermians, national team). 24 June – S. M. Cyril, 86, educator. 28 June – Willie Carrick, 70, footballer (Chelmsford City, Luton Town).
Oscillation Repetitive rhythmic activity in neurons or neural networks. Neural oscillations, such as alpha waves and gamma waves, are observed in brain activity recordings. Otolith organs Structures in the vestibular system (the utricle and saccule) that detect linear acceleration and head position relative to gravity.
16 February – Former footballer Ciaran Dickson is sentenced to six years in prison by the High Court in Glasgow for the hit-and-run killing of Aidan Pilkington in September 2021, when he was more than three times over the drink drive limit. Scotland is to scrap its Super 6 rugby series and reinstate a national "A team" as part of a comprehensive restructuring programme. 17 February – Delegates at the Scottish Labour Party conference pass a resolution calling for an immediate ceasefire in Gaza. Two men are killed in a road traffic accident involving three cars on the B9077 in Maryculter, Aberdeenshire. 20 February – Heather Woodbridge, aged 29, is appointed as leader of Orkney Islands Council, becoming Scotland's youngest council leader and the first woman to lead Orkney Islands Council. The BBC announces plans to reshape the BBC Scotland TV channel, including axing the hour-long news programme The Nine and replacing it with a 30-minute programme. 22 February – Argyll and Bute Council votes to raise its council tax by 10%, and rejects the Scottish Government's council tax freeze by doing so. 23 February – The Scottish Government publishes draft legislation proposing a ban on the sale of disposable vapes in Scotland by 1 April 2025. 24 February – Police Scotland begins an investigation after burnt human remains are found near Motherwell Football Club. 25 February – The Scottish Government confirms that Economy Secretary Màiri McAllan, who is pregnant, will take maternity leave during the summer, becoming the second Scottish Government minister to do so.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.